SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $739,883 | +44.5% | 1,235,198 | +213.7% | 0.00% | – |
| Q2 2023 | $511,860 | -75.1% | 393,738 | -66.3% | 0.00% | – |
| Q1 2023 | $2,055,207 | -41.2% | 1,167,731 | +4.9% | 0.00% | – |
| Q4 2022 | $3,496,987 | -7.0% | 1,113,690 | +45.1% | 0.00% | – |
| Q3 2022 | $3,761,000 | +30.0% | 767,345 | +9.8% | 0.00% | – |
| Q2 2022 | $2,894,000 | -33.0% | 699,069 | -6.0% | 0.00% | – |
| Q1 2022 | $4,321,000 | +34.7% | 743,733 | +73.9% | 0.00% | – |
| Q4 2021 | $3,208,000 | -33.7% | 427,791 | -20.4% | 0.00% | – |
| Q3 2021 | $4,841,000 | -18.2% | 537,460 | +8.7% | 0.00% | – |
| Q2 2021 | $5,921,000 | -26.9% | 494,586 | -23.5% | 0.00% | -100.0% |
| Q1 2021 | $8,099,000 | -7.6% | 646,463 | +15.1% | 0.00% | -50.0% |
| Q4 2020 | $8,767,000 | +224.2% | 561,770 | +96.3% | 0.00% | – |
| Q3 2020 | $2,704,000 | +24.1% | 286,194 | +17.7% | 0.00% | – |
| Q2 2020 | $2,179,000 | +281.6% | 243,171 | +171.5% | 0.00% | – |
| Q1 2020 | $571,000 | -37.9% | 89,574 | -18.5% | 0.00% | – |
| Q4 2019 | $920,000 | -59.6% | 109,879 | -56.3% | 0.00% | – |
| Q3 2019 | $2,275,000 | -28.6% | 251,361 | -15.0% | 0.00% | – |
| Q2 2019 | $3,186,000 | -32.0% | 295,856 | -39.7% | 0.00% | -100.0% |
| Q1 2019 | $4,683,000 | +155.3% | 490,826 | +207.1% | 0.00% | – |
| Q4 2018 | $1,834,000 | -4.1% | 159,812 | +41.6% | 0.00% | – |
| Q3 2018 | $1,912,000 | -43.8% | 112,831 | -52.9% | 0.00% | -100.0% |
| Q2 2018 | $3,400,000 | +105.2% | 239,420 | +174.5% | 0.00% | – |
| Q1 2018 | $1,657,000 | -42.1% | 87,229 | -50.0% | 0.00% | – |
| Q4 2017 | $2,863,000 | +610.4% | 174,586 | +549.7% | 0.00% | – |
| Q3 2017 | $403,000 | +161.7% | 26,872 | +52.9% | 0.00% | – |
| Q2 2017 | $154,000 | -8.9% | 17,577 | -46.1% | 0.00% | – |
| Q1 2017 | $169,000 | +156.1% | 32,625 | +49.9% | 0.00% | – |
| Q4 2016 | $66,000 | -35.9% | 21,764 | -2.1% | 0.00% | – |
| Q3 2016 | $103,000 | -39.1% | 22,230 | -23.8% | 0.00% | – |
| Q2 2016 | $169,000 | +65.7% | 29,157 | +72.6% | 0.00% | – |
| Q1 2016 | $102,000 | -87.6% | 16,896 | -81.2% | 0.00% | – |
| Q4 2015 | $822,000 | +50.5% | 90,016 | -6.9% | 0.00% | – |
| Q3 2015 | $546,000 | -67.4% | 96,685 | -35.9% | 0.00% | -100.0% |
| Q2 2015 | $1,674,000 | +5.9% | 150,908 | +49.9% | 0.00% | 0.0% |
| Q1 2015 | $1,580,000 | -19.5% | 100,694 | -22.0% | 0.00% | 0.0% |
| Q4 2014 | $1,963,000 | +21.5% | 129,039 | -13.9% | 0.00% | – |
| Q3 2014 | $1,616,000 | -44.0% | 149,842 | -20.7% | 0.00% | -100.0% |
| Q2 2014 | $2,886,000 | -58.4% | 189,058 | -50.7% | 0.00% | -50.0% |
| Q1 2014 | $6,933,000 | +55.2% | 383,448 | +19.3% | 0.00% | 0.0% |
| Q4 2013 | $4,466,000 | +46.2% | 321,474 | +10.4% | 0.00% | +100.0% |
| Q3 2013 | $3,055,000 | +10.4% | 291,187 | -17.9% | 0.00% | 0.0% |
| Q2 2013 | $2,768,000 | – | 354,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |